Select for export Effect of psilocin on extracellular dopamine and serotonin levels in the mesoaccumbens and mesocortical pathway in awake rats. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1248/bpb.b14-00315 PubMed 25342005 Copy citation Copy BibTeX Biological and Pharmaceutical Bulletin 2014-10-23 Sakashita Y, Abe K, Katagiri N, Kambe T, Saitoh T, Utsunomiya I Europe PMC Published psilocybinpsilocin Mechanism of ActionReceptor Pharmacology Other More
Select for export P.1.g.005 Serotonergic modulation of emotion processing by the mixed 5-HT1A/2A receptor agonist psilocybin reduces amygdala activation to negative stimuli - a pharmacological fMRI study No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(14)70316-5 Copy citation Copy BibTeX European Neuropsychopharmacology 2014-09-24 Rainer Kraehenmann, Katrin H. Preller, Erich Seifritz, F.X. Vollenweider OpenAlex Published psilocybin Brain ImagingReceptor PharmacologyEmotional Processing Other More
Select for export Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125314527985 PubMed 25083275 Copy citation Copy BibTeX Therapeutic advances in psychopharmacology 2014-07-31 Baumeister D, Barnes G, Giaroli G, Tracy D PubMed Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.bbr.2014.07.016 PubMed 25036425 Copy citation Copy BibTeX Unknown journal 2014-07-14 Halberstadt AL. Europe PMC Published psilocybin Brain ImagingPharmacologyReceptor Pharmacology Clinical Trial More
Select for export Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2014.04.010 PubMed 24882567 Copy citation Copy BibTeX Biological Psychiatry 2014-04-25 Kraehenmann R, Preller KH, Scheidegger M, Pokorny T, Bosch OG, Seifritz E Europe PMC Published psilocybin DepressionAnxietyBrain Imaging Clinical Trial More
Select for export EPA-0137 - EEG power spectra and connectivity changes in animal serotonergic and glutamatergic models of psychosis - implications for treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(14)77609-6 Copy citation Copy BibTeX European Psychiatry 2013-12-31 Tomáš Páleníček, Filip Tylš, M. Fujáková, Anna Kubešová, Pavlína Nováková, L. Kadeřábek OpenAlex Published psilocybinpsilocin Brain ImagingReceptor PharmacologyBiomarkers Other More
Select for export Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113513852 PubMed 24284475 Copy citation Copy BibTeX Journal of Psychopharmacology 2013-11-26 Winstock AR, Kaar S, Borschmann R. Europe PMC Published psilocybin Observational StudyAbuse Liability Observational Study More
Select for export Serotonergic hyperactivity as a potential factor in developmental, acquired and drug-induced synesthesia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fnhum.2013.00657 PubMed 24155703 Copy citation Copy BibTeX Frontiers in Human Neuroscience 2013-10-20 Brogaard B. Europe PMC Published psilocybin Mechanism of ActionReceptor Pharmacology Other More
Select for export Psychedelics and mental health: a population study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0063972 PubMed 23976938 Copy citation Copy BibTeX PLoS ONE 2013-08-18 Krebs TS, Johansen PØ. Europe PMC Published psilocybin DepressionAnxietyPTSD Observational Study More
Select for export Serotonergic hallucinogens as translational models relevant to schizophrenia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1461145713000722 PubMed 23942028 Copy citation Copy BibTeX Unknown journal 2013-08-12 Halberstadt AL, Geyer MA. Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyReview Article Review Article More
Select for export Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/cercor/bht178 PubMed 23861318 Copy citation Copy BibTeX Cerebral Cortex 2013-07-15 Bernasconi F, Schmidt A, Pokorny T, Kometer M, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Observational Study More
Select for export Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1523/jneurosci.3007-12.2013 PubMed 23785166 Copy citation Copy BibTeX Journal of Neuroscience 2013-05-31 Kometer M, Schmidt A, Jäncke L, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyConsciousnessObservational Study Observational Study More
Select for export Animal models of serotonergic psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/cn300138m PubMed 23336043 Copy citation Copy BibTeX Unknown journal 2012-09-23 Hanks JB, González-Maeso J. Europe PMC Published psilocybin AnxietyMechanism of ActionReceptor Pharmacology Review Article More
Select for export Anticholinergic toxicity after the ingestion of serotonergic 'magic mushrooms' Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Pure Amsterdam UMC 2012-05-31 Jacomien Aleman, Mirjam Crul, Peter H. J. van der Voort, Eric J. F. Franssen OpenAlex Published psilocybinpsilocin End-of-Life DistressPharmacologyReceptor Pharmacology Case Report More
Select for export Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2012.04.005 PubMed 22578254 Copy citation Copy BibTeX Biological Psychiatry 2012-05-09 Kometer M, Schmidt A, Bachmann R, Studerus E, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin DepressionMechanism of ActionReceptor Pharmacology Clinical Trial More
Select for export Psychedelic synaesthesia: Evidence for a serotonergic role in synaesthesia Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1163/187847612x646956 Copy citation Copy BibTeX Seeing and Perceiving 2011-12-31 David Luke, Devin B. Terhune, Ross Friday OpenAlex Published psilocybin Mechanism of ActionReceptor PharmacologyConsciousness Observational Study More
Select for export Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2011.01.017 PubMed 21256140 Copy citation Copy BibTeX Unknown journal 2011-01-19 Halberstadt AL, Geyer MA. Europe PMC Published psilocybin End-of-Life DistressNeuroplasticityReceptor Pharmacology Review Article More
Select for export The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopsych.2010.10.002 PubMed 21126732 Copy citation Copy BibTeX Biological Psychiatry 2010-12-02 Kometer M, Cahn BR, Andel D, Carter OL, Vollenweider FX. Europe PMC Published psilocybin Receptor PharmacologyConsciousness Other More
Select for export Investigating the Mechanisms of Hallucinogen-Induced Visions Using 3,4-Methylenedioxyamphetamine (MDA): A Randomized Controlled Trial in Humans Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0014074 PubMed 21152030 Copy citation Copy BibTeX PLoS ONE 2010-12-01 Matthew J. Baggott, Jennifer D. Siegrist, Gantt P. Galloway, Lynn C. Robertson, Jeremy Coyle, John Mendelson OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Randomized Controlled Trial More
Select for export Salvia divinorum use and phenomenology: results from an online survey. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881110385596 PubMed 20937616 Copy citation Copy BibTeX Unknown journal 2010-10-10 Sumnall HR, Measham F, Brandt SD, Cole JC. Europe PMC Published psilocin AddictionReceptor PharmacologyObservational Study Observational Study More
